Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
92.2M
-
Number of holders
-
130
-
Total 13F shares, excl. options
-
58.1M
-
Shares change
-
+1.16M
-
Total reported value, excl. options
-
$92.4M
-
Value change
-
+$1.34M
-
Put/Call ratio
-
4.55
-
Number of buys
-
69
-
Number of sells
-
-48
-
Price
-
$1.59
Significant Holders of Caribou Biosciences, Inc. - Common Stock (CRBU) as of Q4 2024
157 filings reported holding CRBU - Caribou Biosciences, Inc. - Common Stock as of Q4 2024.
Caribou Biosciences, Inc. - Common Stock (CRBU) has 130 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 58.1M shares
of 92.2M outstanding shares and own 63.06% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (6.56M shares), Pfizer Inc (4.69M shares), VANGUARD GROUP INC (4.57M shares), PFM Health Sciences, LP (3.88M shares), MORGAN STANLEY (2.75M shares), JPMORGAN CHASE & CO (2.5M shares), Kynam Capital Management, LP (2.41M shares), Schonfeld Strategic Advisors LLC (2.11M shares), Elmwood Wealth Management, Inc. (2.03M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.97M shares).
This table shows the top 130 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.